Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Science & Innovation
A Picture of Pain: What Life is Really Like with Chronic Pain
Almost everyone has experienced some type of acute, or temporary, pain in their lives. Acute pain is a protective response to tissue injury that typically resolves with the healing process and lasts less than three months. However, for one in five people around the world, their pain persists for longer than three months and is considered chronic. ,Some people may suffer from diseases or disorders that cause their chronic pain, while others may have an injury or accident that causes long-term or...
Science & Innovation
Collection and Use of Real-World Data Continues to Grow Around the World
Conducting real-world data (RWD) analyses to generate real-world evidence (RWE) is a growing practice in the healthcare community. RWE provides helpful information that complements clinical trial findings and may help fill knowledge gaps related to how a medication is used in real-world medical settings. These data consist of de-identified patient-related data collected from various sources, including but not limited to, anonymized electronic medical records, claims databases, health surveys...
Science & Innovation
One Family’s Hemophilia Journey
This microdocumentary shares the moving story of a family with two young sons who have severe hemophilia, giving us a glimpse into their history and treatment routine. Hemophilia is a rare bleeding disorder in which the body is unable to properly create a blood clot. Beyond external bleeding, like a cut, people with hemophilia also bleed internally and in their joints, which can lead to crippling arthritis later in life. The story highlights the significant progress made in this therapeutic...
Science & Innovation
4 Breakthroughs in Breast Cancer Treatment
One out of eight women will develop invasive breast cancer in her lifetime. (Science Photo Library)Advances in genetic testing, immunotherapy, and other areas are transforming the way we treat breast cancer.Survival rates for breast cancer have improved in recent decades. That’s good news for the approximately 250,000 women expected to be diagnosed in the U.S. in 2016. In recent years, scientists have been harnessing genetics, immunotherapy, and other innovative treatments to more precisely...
Science & Innovation
Tackling Antibiotic Resistance
Pfizer and industry partners present roadmap for overcoming the threat that resistance poses. In an unprecedented collaboration, today, Pfizer and 13 industry partners released a comprehensive plan of action that lays out four key commitments we pledge to deliver by 2020 to reduce the rising incidence of antimicrobial resistance. Antimicrobial resistance is a natural process by which bacteria and other microbes develop resistance to the drugs commonly used to treat infections, including...
Science & Innovation
The World Federation of Hemophilia Twinning Program
Celebrating Advancements in Hemophilia Patient Care and Treatment In 1994, the World Federation of Hemophilia (WFH) recognized the need for a program to unite hemophilia treatment centers and patient organizations across the world to share information, best practices, and resources to help improve the treatment and care of those living with hemophilia. As a result, the WFH Twinning Program was created to facilitate short-term collaborative partnerships between medical professionals and...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.